|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"kuo yh"
Showing items 1-25 of 116 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2025-Fe-03 |
Synthesis, anticancer evaluation and structure-activity relationship of Taiwanin a derivatives
|
Chang, CI;Kuo, CC;Wein, YS;Chao, CY;Chen, YC;Chang, JY;Kuo, YH |
| 國家衛生研究院 |
2025-09-30 |
PIP5K3 upregulation correlates with unfavorable prognosis in patients with nasopharyngeal carcinoma
|
Yao, SC;Wu, HC;Yang, CC;Lin, YT;Li, CF;Chang, SL;Kuo, YH |
| 國家衛生研究院 |
2025-09-04 |
Long non-coding RNA C20orf56 as a predictor of response to neoadjuvant CCRT and survival rates of rectal cancers
|
Chen, CI;Yeh, CF;Yang, CC;Kao, YK;Chen, PC;Yang, PW;Lee, SW;Tian, YF;Kuo, YH;Wu, LC;Li, CF;Chien, YC;Chang, IW |
| 國家衛生研究院 |
2025-09-01 |
Prognostic impact of RPL15 overexpression in intrahepatic cholangiocarcinoma: A marker of aggressive tumor behavior
|
Wang, WC;Huang, CJ;Hsu, HP;Kuo, YH;Ong, KH;Sun, DP;Tian, YF;Chou, CL;Chan, TC;Hsing, CH;Li, WS;He, HL |
| 國家衛生研究院 |
2025-04-16 |
Physalin A induces apoptosis through conjugating with Fas-FADD cell death receptor in human oral squamous carcinoma cells and suppresses HSC-3 cell xenograft tumors in NOD/SCID mice
|
Chueh, FS;Hsu, SY;Lai, KC;Liu, YC;Lyu, PC;Kuo, YH;Huang, YP;Hsieh, WT |
| 國家衛生研究院 |
2025-03-28 |
Prognostic role of claudin-18.2 in intrahepatic cholangiocarcinoma
|
Kuo, YH;Ong, KH;Sun, DP;Tian, YF;Chou, CL;Chan, TC;Hsing, CH;Li, WS;Li, CF;Shiue, YL |
| 國家衛生研究院 |
2024-11 |
DBPR116, a prodrug of BPRMU191, in combination with naltrexone as a safer opioid analgesic than morphine via peripheral administration
|
Lin, SY;Chang, YC;Tien, YW;Kuo, YH;Chang, HF;Ou, LC;Chen, YP;Chang, KH;Hsu, YT;Huang, YC;Yang, CM;Law, PY;Xi, JH;Tao, PL;Loh, HH;Yeh, TK;Zhuang, H;Hsieh, HP;Shih, C;Chen, CT;Yeh, SH;Ueng, SH |
| 國家衛生研究院 |
2024-07-17 |
Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia
|
Huang, YH;Lin, SY;Ou, LC;Huang, WC;Chao, PK;Chang, YC;Chang, HF;Lee, PT;Yeh, TK;Kuo, YH;Tien, YW;Xi, JH;Tao, PL;Chen, PY;Chuang, JY;Shih, C;Chen, CT;Tung, CW;Loh, HH;Ueng, SH;Yeh, SH |
| 國家衛生研究院 |
2023-12-15 |
Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma
|
Ong, KH;Lai, HY;Sun, DP;Chen, TJ;Huang, SKH;Tian, YF;Chou, CL;Shiue, YL;Chan, TC;Li, CF;Kuo, YH |
| 國家衛生研究院 |
2023-10-30 |
LAMC2 is a potential prognostic biomarker for cholangiocarcinoma
|
Ong, KH;Hsieh, YY;Lai, HY;Sun, DP;Chen, TJ;Huang, SKH;Tian, YF;Chou, CL;Shiue, YL;Wu, HC;Chan, TC;Tsai, HH;Li, CF;Kuo, YH |
| 國家衛生研究院 |
2023-10-14 |
Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma
|
Ong, KH;Hsieh, YY;Lai, HY;Sun, DP;Chen, TJ;Huang, SKH;Tian, YF;Chou, CL;Shiue, YL;Wu, HC;Chan, TC;Tsai, HH;Li, CF;Su, PA;Kuo, YH |
| 國家衛生研究院 |
2023-06-28 |
Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma
|
Liang, PI;Lai, HY;Chan, TC;Li, WM;Hsing, CH;Huang, SK;Hsieh, KL;Tseng, WH;Chen, TJ;Li, WS;Chen, HD;Kuo, YH;Li, CF |
| 國家衛生研究院 |
2023-04-19 |
Prognostic significance of DNA topoisomerase II Alpha (TOP2A) in cholangiocarcinoma
|
Ong, KH;Lai, HY;Sun, DP;Chen, TJ;Huang, SK;Tian, YF;Chou, CL;Shiue, YL;Chan, TC;Li, CF;Kuo, YH |
| 國家衛生研究院 |
2023-03-28 |
Synthesis and structure–activity relationship of salvinal derivatives as potent microtubule inhibitors
|
Chang, CI;Hsieh, CC;Wein, YS;Kuo, CC;Chang, CY;Lung, J;Cherng, JY;Chu, PC;Chang, JY;Kuo, YH |
| 國家衛生研究院 |
2023-03-27 |
Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab
|
Lin, YT;Li, CF;Wu, HC;Jan, YH;Kuo, YH |
| 國家衛生研究院 |
2023-02-25 |
Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder
|
He, HL;Lai, HY;Chan, TC;Hsing, CH;Huang, SK;Hsieh, KL;Chen, TJ;Li, WS;Kuo, YH;Shiue, YL;Li, CF |
| 國家衛生研究院 |
2022-11 |
High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT
|
Chen, HP;Chen, CI;Liu, KW;Chen, TJ;Tian, YF;Kuo, YH;Li, WS;Tsai, HH;Wu, LC;Yeh, CF;Li, CF;Chou, CL;Lai, HY |
| 國家衛生研究院 |
2022-10-11 |
Upregulated ubiquitin D is a favorable prognostic indicator for rectal cancer patients undergoing preoperative concurrent chemoradiotherapy
|
Chou, CL;Chen, TJ;Li, WS;Lee, SW;Yang, CC;Tian, YF;Lin, CY;He, HL;Wu, HC;Shiue, YL;Li, CF;Kuo, YH |
| 國家衛生研究院 |
2022-09 |
High MT2A expression predicts worse prognosis in patients with urothelial carcinoma
|
Li, WM;Ke, HL;Kuo, YH;Lai, HY;Chan, TC;Hsing, CH;Hsieh, KL;Li, WS;Chen, TJ;Wei, YC;Wu, WJ;Huang, SK;Li, CF |
| 國家衛生研究院 |
2022-06-30 |
Upregulation of cartilage oligomeric matrix protein predicts poor prognosis in urothelial carcinoma
|
Kuo, YH;Lai, HY;Chan, TC;Hsing, CH;Huang, SK;Hsieh, KL;Chen, TJ;Li, WS;Lu, JC;Li, CF |
| 國家衛生研究院 |
2022-03-16 |
High stromal SFRP2 expression in urothelial carcinoma confers an unfavorable prognosis
|
Lai, HY;Chiu, CC;Kuo, YH;Tsai, HH;Wu, LC;Tseng, WH;Liu, CL;Hsing, CH;Huang, SK;Li, CF |
| 國家衛生研究院 |
2022-02-11 |
Angiogenesis driven by the CEBPD–hsa-miR-429–VEGFA signaling axis promotes urothelial carcinoma progression
|
Chan, TC;Hsing, CH;Shiue, YL;Huang, SK;Hsieh, KL;Kuo, YH;Li, CF |
| 國家衛生研究院 |
2021-11-10 |
Complete and durable response to nivolumab in recurrent poorly differentiated pancreatic neuroendocrine carcinoma with high tumor mutational burden
|
Kang, NW;Tan, KT;Li, CF;Kuo, YH |
| 國家衛生研究院 |
2021-09-23 |
Secondary metabolites with anti-inflammatory activities from one actinobacteria amycolatopsis Taiwanensis
|
Su, YS;Wu, MD;Chen, JJ;Cheng, MJ;Kuo, YH;Chai, CY;Kwan, AL |
| 國家衛生研究院 |
2021-09-14 |
Two new chromones and a new coumarin from the fruit of Cnidium monnieri (L.) Cusson
|
Huang, HC;Lin, CH;Kuo, CC;Wu, MD;Cheng, MJ;Chen, JJ;Chao, CY;Huang, GJ;Kuo, YH |
显示项目 1-25 / 116 (共5页)
1 2 3 4 5 > >>
每页显示[10|25|50]项目
|
